Entero Healthcare Solutions Limited is an India-based technology-driven and integrated healthcare products distribution company. It offers a range of pharmaceuticals and other healthcare products to approximately 86,200 retail pharmacies and healthcare practitioners (HCPs) across 492 districts in India. Its portfolio includes over 68,900 SKUs from more than 2000 pharma companies. The Company is a supplier to over 3,500 hospitals across India, including corporate hospital chains. It has over a network of 104 warehouses. Its technology solutions include Entero Direct, Entero CRM, Entero ERP, and Teqtic. Its Entero Direct platform is a cloud-based software-as-a-service solution that allows retailers to order their procurement needs. The Entero CRM application is a customer relationship management tool that manages and analyzes its interactions with customers, in order to customer retention and wallet share. It also offers its products through the Aayu Chemist app and Medcords platform.As of 26 May 2026, ENTERO HEALTHCARE SOLU L share price is ₹1,349.40. The stock opened at ₹1,361.00, compared to its previous close of ₹1,354.40. During today's trading session, ENTERO HEALTHCARE SOLU L share price moved in the range of ₹1,275.10 to ₹1,390.00, with an average price of ₹1,332.55 for the day. Looking at its last 52-week, the stock has touched a low of ₹1,275.10 and a high of ₹1,390.00. On the performance front, ENTERO HEALTHCARE SOLU L share price has increased by 27.31% over the last six months and is down 5.45% on a year-on-year basis.
The market capitalization of ENTERO HEALTHCARE SOLU L is ₹5,887 Crs, with a P/E ratio of 44.5 and a dividend yield of 0.00%.